tm logo
SYRCELT
Live/Registered
REGISTERED

on 10 Dec 2024

Last Applicant/ Owned by

B-6180 Courcelles

BE

Serial Number

79373376 filed on 07th Apr 2023

Registration Number

7592418 registered on 10th Dec 2024

in the Principal Register

Correspondent Address

Bradley M. Stohry

Bradley M. Stohry Reichel Stohry Dean LLP

Indianapolis, IN 46220

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

SYRCELT

Pharmaceutical research and development for the pharmaceutical industry; medical and pharmacological research services; research and development services relating to medicines; development of pharmaceutical preparations and medicines; development of pharmaceutical products Chemical products for use in the pharmaceutical industry, namely, chemical additives and preservatives for use in the manufac Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Pharmaceutical research and development for the pharmaceutical industry; medical and pharmacological research services; research and development services relating to medicines; development of pharmaceutical preparations and medicines; development of pharmaceutical products


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical products, namely, syrups, preparations in the form of granules, and liquid pharmaceutical suspensions, for pharmaceutical purposes for the treatment of cardiovascular, digestive, neurological, endocrine, respiratory, immune, muscular, urinary, reproductive, nutritional and skeletal diseases, and pharmaceutical preparations for the treatment of cardiovascular, digestive, neurological, endocrine, respiratory, immune, muscular, urinary, reproductive, nutritional and skeletal diseases; medicines, namely, syrups, preparations in the form of granules, and liquid pharmaceutical suspensions, for pharmaceutical purposes for the treatment of cardiovascular, digestive, neurological, endocrine, respiratory, immune, muscular, urinary, reproductive, nutritional and skeletal diseases; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents, namely, medicine release agents in the form of gastro-resistant and controlled release microparticles for the controlled release of active ingredients for a wide range of pharmaceutical products; drug delivery agents, namely, medicine delivery agents in the form of granulated powders for the controlled release of active ingredients for a wide range of pharmaceutical products; syrups for pharmaceutical use for the treatment of cardiovascular, digestive, neurological, endocrine, respiratory, immune, muscular, urinary, reproductive, nutritional and skeletal diseases; syrups being medicines for the treatment of cardiovascular, digestive, neurological, endocrine, respiratory, immune, muscular, urinary, reproductive, nutritional and skeletal diseases; syringes pre-filled with syrups for the treatment of cardiovascular, digestive, neurological, endocrine, respiratory, immune, muscular, urinary, reproductive, nutritional and skeletal diseases; medicines being esomeprazole for oral administration; medicines being omeprazole for oral administration; central nervous system stimulants; hormones for medical use; Pharmaceutical products for the treatment of gastrointestinal disorders; soporifics


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [001]
Chemical Products


Chemical products for use in the pharmaceutical industry, namely, chemical additives and preservatives for use in the manufacture of pharmaceuticals; active chemical ingredients for manufacture of pharmaceutical products for treating cardiovascular, digestive, neurological, endocrine, respiratory, immune, muscular, urinary, reproductive, nutritional and skeletal diseases; chemical additives for use as binding agents in the manufacture of pharmaceuticals for treating cardiovascular, digestive, neurological, endocrine, respiratory, immune, muscular, urinary, reproductive, nutritional and skeletal diseases; chemical carrier excipients for use in the manufacture of pharmaceutical preparations; chemical excipients for the manufacture of pharmaceutical preparations; raw material, namely, cellulose microspheres and microspheres made of cellulose, sugar, and starch for use in the manufacture of pharmaceuticals; microcrystalline cellulose microspheres for use in the manufacture of pharmaceuticals; preserving agents for the pharmaceutical industry, namely, antioxidants and antimicrobials for use in the manufacture of pharmaceuticals; carrier excipients for use in the manufacture of pharmaceutical preparations; excipients for pharmaceutical preparation manufacture


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79373376

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
10th Dec 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
10th Dec 2024REGISTERED-PRINCIPAL REGISTER
04th Dec 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04th Dec 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
10th Sep 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10th Sep 2024PUBLISHED FOR OPPOSITION
21st Aug 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07th Aug 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07th Aug 2024EXAMINER'S AMENDMENT ENTERED
07th Aug 2024EXAMINERS AMENDMENT E-MAILED